knowledge -WSS

knowledge

author：hotspot 2025-09-27 23:00:32 - browse：29781

CHICAGO — The Food and Drug Administration’s top oncologist reiterated that the agency doesn’t want drugmakers applying for approval with data from trials solely run in a single country such as China, but instead wants to see companies conducting studies across the world.

The comments by Richard Pazdur, director of the FDA’s Oncology Center of Excellence, came as more drugmakers report data from China, with Miami-based Summit Therapeutics earlier this week announcing that its investigational drug beat Merck’s blockbuster Keytruda in a head-to-head non-small cell lung cancer study in China.

It’s not a blanket policy, and the agency would assess each company’s submission to see how applicable the data are to the U.S. population, but in general, “I am pro multi-regional trials,” Pazdur said Friday at STAT@ASCO, STAT’s event at the American Society of Clinical Oncology annual meeting.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Wegovy’s successful heart trial raises vital question about weight loss

WSS

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Emergent cuts jobs, executive role in business shake

Former reverend arrested for allegedly killing 8

Friends ask where James Watson's attitudes about race came from

Drastic changes should bring profitability, startup health insurers say

American woman, child freed after being kidnapped in Haiti last month

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Drastic changes should bring profitability, startup health insurers say

Drug repurposing or repositioning? The language matters

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

ChatGPT in medicine: STAT answers readers' burning questions

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

How one medical school became remarkably diverse

Device maker Teleflex to acquire urology company for $600M

Heart attack and stroke risk calculators need revising

A biotech analyst on neuroscience, placebo effect, not over

hotspot

Anavex keeps shifting the goalposts in its clinical trials

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Rise in cancer among younger people worries and puzzles doctors

Why patients can’t get everything they want on drug pricing

Senate panel puts off hardest PBM reforms for another day

Biogen says it will cut costs by $700 million, slash 1,000 jobs

leisure time

leisure time

knowledge

leisure time